AU2882699A - Stabilizing composition for pharmaceutical dosage forms - Google Patents
Stabilizing composition for pharmaceutical dosage formsInfo
- Publication number
- AU2882699A AU2882699A AU28826/99A AU2882699A AU2882699A AU 2882699 A AU2882699 A AU 2882699A AU 28826/99 A AU28826/99 A AU 28826/99A AU 2882699 A AU2882699 A AU 2882699A AU 2882699 A AU2882699 A AU 2882699A
- Authority
- AU
- Australia
- Prior art keywords
- dosage forms
- pharmaceutical dosage
- stabilizing composition
- stabilizing
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7622598P | 1998-02-27 | 1998-02-27 | |
| US60076225 | 1998-02-27 | ||
| PCT/US1999/004361 WO1999043302A1 (en) | 1998-02-27 | 1999-02-26 | Stabilizing composition for pharmaceutical dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2882699A true AU2882699A (en) | 1999-09-15 |
Family
ID=22130698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28826/99A Abandoned AU2882699A (en) | 1998-02-27 | 1999-02-26 | Stabilizing composition for pharmaceutical dosage forms |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2882699A (en) |
| WO (1) | WO1999043302A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10231965B2 (en) | 2014-02-20 | 2019-03-19 | Ignyta, Inc. | Molecules for administration to ROS1 mutant cancer cells |
| US10085979B2 (en) | 2014-12-02 | 2018-10-02 | Ignyta, Inc. | Combinations for the treatment of neuroblastoma |
| JP7061068B2 (en) | 2015-12-18 | 2022-04-27 | イグナイタ インコーポレイテッド | Combination drug for cancer treatment |
| EP3654952A1 (en) | 2017-07-19 | 2020-05-27 | Ignyta, Inc. | Pharmaceutical compositions comprising entrectinib |
| JP7311498B2 (en) | 2017-10-17 | 2023-07-19 | イグナイタ インコーポレイテッド | Pharmaceutical compositions and dosage forms |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212195A (en) * | 1992-05-13 | 1993-05-18 | Syntex (U.S.A.) Inc. | Substituted indole antagonists derivatives which are angiotensin II |
-
1999
- 1999-02-26 AU AU28826/99A patent/AU2882699A/en not_active Abandoned
- 1999-02-26 WO PCT/US1999/004361 patent/WO1999043302A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999043302A1 (en) | 1999-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1071301A (en) | Pharmaceutical compounds | |
| AU4413299A (en) | Stabilized pharmaceutical compositions | |
| HUP0103256A3 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds | |
| GB9817118D0 (en) | Pharmaceutical compounds | |
| AU6740298A (en) | Pharmaceutical composition | |
| PT1466615E (en) | Pharmaceutical composition | |
| GB9810886D0 (en) | Pharmaceutical compounds | |
| AU1574900A (en) | Pharmaceutical compositions containing insulin | |
| AU3556400A (en) | Pharmaceutical compositions | |
| AU1887401A (en) | Medicinal composition | |
| PL343769A1 (en) | Pharmaceutical composition | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
| AU6460400A (en) | Pharmaceutical compositions | |
| AU7937500A (en) | Pharmaceutical composition containing midazolam | |
| AU9343098A (en) | Pharmaceutical composition | |
| AU5722900A (en) | Pharmaceutical compounds | |
| AU6460200A (en) | Pharmaceutical compositions | |
| AUPP332898A0 (en) | Pharmaceutical composition | |
| AU6480299A (en) | Pharmaceutical compounds | |
| AU2882699A (en) | Stabilizing composition for pharmaceutical dosage forms | |
| AU5525199A (en) | N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU1688099A (en) | Pharmaceutical preparation | |
| AU6460100A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |